Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Adverum Biotechnologies, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 118 | 1 | 110 | −7 |
| Shares | 79.2M | 480.0K | 70.0M | −8.75M (−11.1%) |
| Value | $280.4M | $1.68M | $151.2M | −$127.6M (−45.8%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 847,967 | $1.84M | 0.01% |
| Connor, Clark & Lunn Investment Management Ltd. | 368,405 | $799.0K | 0.00% |
| 683 Capital Management, LLC | 200,000 | $434.0K | 0.02% |
| Jacobs Levy Equity Management, Inc | 139,604 | $303.0K | 0.00% |
| SG Americas Securities, LLC | 68,934 | $150.0K | 0.00% |
| Pinz Capital Management, LP | 53,600 | $116.0K | 0.05% |
| Marquette Asset Management, LLC | 45,603 | $99.0K | 0.02% |
| Public Employees Retirement System of Ohio | 32,200 | $70.0K | 0.00% |
| Qube Research & Technologies Ltd | 23,662 | $51.0K | 0.00% |
| Alpine Global Management, LLC | 13,054 | $28.0K | 0.01% |
| Jane Street Group, LLC | 12,040 | $26.0K | 0.00% |
| Dark Forest Capital Management LP | 8,250 | $18.0K | 0.01% |
| Point72 Hong Kong Ltd | 2,736 | $6.00K | 0.00% |
Sold out (20)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 2,827,000 | $9.89M |
| Virtu Financial LLC | 73,955 | $259.0K |
| Allianz Asset Management GmbH | 60,468 | $212.0K |
| Walleye Trading LLC | 54,711 | $191.0K |
| Manufacturers Life Insurance Company, The | 53,590 | $188.0K |
| Acadian Asset Management LLC | 41,300 | $144.0K |
| PDT Partners, LLC | 40,315 | $141.0K |
| DekaBank Deutsche Girozentrale | 32,500 | $113.0K |
| Chicago Partners Investment Group LLC | 46,151 | $112.0K |
| Quantbot Technologies LP | 31,400 | $109.0K |
| Truist Financial Corp | 25,500 | $89.0K |
| Old Well Partners, LLC | 18,440 | $65.0K |
| Dynamic Technology Lab Private Ltd | 15,371 | $54.0K |
| Meeder Asset Management Inc | 6,877 | $24.0K |
| Hershey Trust Co | 3,710 | $13.0K |
| KBC Group NV | 2,100 | $7.00K |
| US Bancorp | 560 | $2.00K |
| TCI Wealth Advisors, Inc. | 653 | $2.00K |
| Lindbrook Capital, LLC | 410 | $1.00K |
| Global Retirement Partners, LLC | 34 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| San Francisco Sentry Investment Group (Ca) | 480,000 | $1.68M |